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ABSTRACT 
 
To date, cytogenetic damage has been assessed in blood lymphocytes from more than 30 astronauts 
before and after they participated in long-duration space missions of three months or more on board the 
International Space Station. Chromosome damage was assessed using fluorescence in situ hybridization 
whole chromosome analysis techniques. For all individuals, the frequency of chromosome damage 
measured within a month of return from space was higher than their prefight yield, and biodosimetry 
estimates were within the range expected from physical dosimetry. Follow up analyses have been 
performed on most of the astronauts at intervals ranging from around 6 months to many years after flight, 
and the cytogenetic effects of repeat long-duration missions have so far been assessed in four individuals.  
Chromosomal aberrations in peripheral blood lymphocytes have been validated as biomarkers of cancer 
risk and cytogenetic damage can therefore be used to characterize excess health risk incurred by 
individual crewmembers after their respective missions.  Traditional risk assessment models are based on 
epidemiological data obtained on Earth in cohorts exposed predominantly to acute doses of gamma-rays, 
and the extrapolation to the space environment is highly problematic, involving very large uncertainties. 
Cytogenetic damage could play a key role in reducing uncertainty in risk estimation because it is incurred 
directly in the space environment, using specimens from the astronauts themselves. 
Relative cancer risks were estimated from the biodosimetry data using the quantitative approach derived 
from the European Study Group on Cytogenetic Biomarkers and Health database. Astronauts were 
categorized into low, medium, or high tertiles according to their yield of chromosome damage. Age 
adjusted tertile rankings were used to estimate cancer risk and results were compared with values 
obtained using traditional modeling approaches. Individual tertile rankings increased after space flight 
and analysis of follow up samples indicated that the tertile rankings remained in the high category for 
more than 50% of the individuals assessed so far.  Crewmembers that shift and remain in the high 
category are projected to have increased life-time cancer risk 
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